QLGN - Watch for Continued Losses in Shares of Qualigen Therapeutics Inc. (QLGN)
Shares of Qualigen Therapeutics Inc. (NASDAQ:QLGN) traded today at $1.76, breaking its 52-week low. Approximately 1.3 million shares have changed hands today, as compared to an average 30-day volume of 892,000 shares.
Qualigen Therapeutics Inc. (NASDAQ:QLGN) has potential upside of 46.3% based on a current price of $1.77 and analysts' consensus price target of $2.59.
Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.
In the past 52 weeks, Qualigen Therapeutics Inc. share prices are bracketed by a current low of $1.76 and a high of $19.75 and is now at $1.77.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer